The Chandigarh cardiologist and the referral machine

Her income oscillates. This year it was downward — ₹72,000 gross revenue in May against her baseline expectation of ₹80,000 per month. The pattern is familiar: CGHS reimbursement rates fixed at ₹600 per consultation since 2022, her clinic rent at ₹60,000 per month, staff costs at ₹35,000, utilities another ₹15,000. The arithmetic narrows each quarter. She needs 40 to 50 CGHS consultations monthly just to cover the fixed costs. If she sees only what the patient's presentation requires, she will not reach her baseline. The economics of Chandigarh's private practice point toward investigation, not restraint.

What is unusual is what happened one April morning when a call from PGIMER crystallised the pressure she had been absorbing as ambient noise — and made her realise that the problem was not her judgment. It was the system that surrounded it.

🗓️ The annual ritual

PGIMER — the Postgraduate Institute of Medical Education & Research — sits at the apex of North India's medical ecosystem. It is India's premier public hospital, the continent's largest postgraduate teaching institution, and draws tertiary referrals from Punjab, Haryana, Himachal Pradesh, and the hill states. A consultant call from PGIMER is a normal event in Chandigarh's medical practice. It signals that a patient has been referred in by a general practitioner, that the GP has had the prudent instinct to refer before taking the liability of a missed diagnosis, and that the GP has asked the nearest available specialist — in this case, Priya — for an assessment before escalation.

This is, on paper, a rational division of labour: primary care identifies risk, calls specialist, specialist confirms or refutes, specialist refers or manages. In practice, the division creates an expectation ecosystem. The GP expects a specialist to either confirm the referral or provide a letter saying "no further workup needed." The specialist expects to do some investigation as evidence that the assessment was thorough. The tertiary center expects investigation to be documented in any case where symptoms exist, even if resolved. The pressure is not malice. It is architecture.

1. 📞

   GP sees chest pain

   General practitioner performs ECG, sees it is normal, but given liability risk of missing acute coronary syndrome, refers to cardiologist for specialist assessment before reassuring the patient.

2. 🩺

   Specialist assesses

   Cardiologist reviews presentation, performs clinical exam. Pre-test probability is low. Clinical logic suggests observation. Financial logic and institutional precedent suggest at least baseline imaging.

3. 📨

   Tertiary center inquires

   PGIMER, on receipt of assessment, gently questions whether imaging was omitted. Not a directive—a question. But framed as institutional expectation: 'Do you want to reconsider?'

4. 💸

   Investigation proceeds

   Specialist orders imaging. Patient receives reassurance. System receives cost. Clinical management unchanged. Specialist receives CGHS reimbursement (₹1,500 echo) that exceeds direct cost margin.

⚠️ What very nearly happened

On April 3, 2026, at 10:47 AM, Priya's clinic phone rang. The voice was formal, English-educated, the intonation of government medical institutions: "Dr. Kapoor? This is Dr. Anjali Verma from PGIMER Cardiothoracic Unit. I have a patient referred in by their GP — Mr. Vikram Singh, fifty-two years old, presented with chest pain, was seen at a private clinic in Sector 9, and the attending physician has requested your opinion before referral to us."

The presentation, when Dr. Verma outlined it, was textbook for low-risk chest pain. Vikram was fifty-two, no prior cardiac history, no documented risk factors. The pain came on when he bent over the weekend — pleuritic, movement-related, already improving. The GP had done an ECG. Normal. Blood pressure normal. The family doctor was nervous. He wanted a cardiologist's sign-off.

What Priya calculated in thirty seconds of silence was the pre-test probability. Pleuritic pain with a clear precipitant, no risk factors, normal ECG, stable vitals. Musculoskeletal pain, viral syndrome, or anxiety — the pre-test probability of acute coronary syndrome was 5 to 10 percent. In that risk stratum, ordering investigations was as likely to generate false positives as to catch disease. The family doctor had made the right call: do not investigate in primary care, refer for specialist assessment. But by referring, the GP had set up an expectation.

"Tell me," Priya said, "what does the patient think the pain is?"

"He thinks it might be musculoskeletal. He strained his back over the weekend. The pain came on the same day."

"And the family doctor has already told him it's probably musculoskeletal?"

"Yes. But the family doctor wanted it ruled out by a cardiologist."

"Send him to my clinic. I can see him this afternoon at 4 PM."

What Priya did not say to PGIMER was what she was calculating in the moment after the call. The family doctor had given clinically correct advice but institutionally risky advice. In Chandigarh's medical ecosystem, a GP who sees chest pain and reassures the patient without a cardiologist's confirmation is taking a reputational gamble. If the patient later has an MI, the chart would show "reassured without specialist input" and someone would ask why. The cardiologist, by contrast, has institutional armour: I saw the patient, I did appropriate testing, I referred or did not refer based on findings. The system rewards documentation and referral, not restraint and reassurance.

But there was a second calculation. If Priya saw Vikram in her clinic, the CGHS reimbursement was ₹600 flat. Her cost for the consultation — staff time, utilities, materials — was approximately ₹200. Gross margin: ₹400. If she did a baseline ECG, the clinic absorbed the ₹300 cost; CGHS did not reimburse beyond the base consultation. If she did an echocardiogram, the CGHS reimbursement was ₹1,500 against material costs of approximately ₹200. Gross margin on the echo: ₹1,300. On the consultation: ₹400.

But if she did not do an echo and the patient later had an event, the chart would read "chest pain evaluation, no imaging" and liability would follow. The financial logic pointed toward investigation. The clinical logic pointed toward restraint. The two arrows did not align.

"આ પણ મેડિસિન છે, અને આ પણ બિઝનેસ છે — પણ બંને એક સાથે ચાલી શક્યાં નથી."

— This is also medicine, and this is also business — but both cannot run together.

🌗 What changed

Vikram arrived at 4 PM. Fifty-two, overweight by his own account, IT job, sit-down work. The pain was sharp, worse when he bent forward, much better when he lay still. He had not had the pain for eighteen hours. His ECG from the family doctor was completely normal — no ischemic changes, no arrhythmia. Priya took a focused history. Cardiovascular exam: normal heart sounds, no murmurs, no signs of heart failure. Risk factors: cholesterol untreated ("probably high, I have not checked in years"), blood pressure 130/80, no smoking, occasional alcohol, rare exercise.

The pre-test probability in her head: intermediate-risk baseline (fifty-two, overweight, sedentary, untreated cholesterol) shifted back toward low-risk by the presentation (pleuritic, clear cause, resolving) and further back by the normal exam and normal ECG. Acute coronary syndrome risk on this day: 8 to 12 percent.

Here is what she said: "Your pain is almost certainly musculoskeletal. The fact that it came on when you bent, that it is worse with movement, and that it is already improving are all consistent with a muscle or ligament strain. Your ECG is normal, which is very reassuring. What I want to do is send you for a blood test — a troponin test, which is a cardiac enzyme that would be elevated if you had a heart attack. I want you to come back in three days for a follow-up. If the pain is completely gone and the troponin is normal, you do not need any further cardiac imaging."

Vikram asked the natural question: "And if the troponin is high?"

"Then we have a different situation, and we do further testing. But I do not expect it to be high."

The troponin came back the next day. 0.02 ng/mL — normal. Cutoff for abnormality is 0.04. Vikram texted: pain completely resolved, back to work, feeling fine.

Priya sent a follow-up: "Great. No further cardiac workup needed. Take care of your posture at work and do some stretching. See you only if pain comes back."

One week later, Priya got an email from PGIMER. It was gentle, institutional language, the kind of message that does not sound like pressure but functions as pressure. Dr. Verma noted that Vikram had been evaluated, troponin was done, symptoms resolved. But — the email said — given his risk factors (age 52, sedentary, untreated cholesterol), would Priya consider repeat ECG or imaging at six weeks to assess baseline cardiac structure and function?

The question was framed as a professional courtesy. What it was asking, in the register of institutional medicine, was: are you sure you are not missing something? Are you sure your restraint is not a gap?

Priya sat at her desk that afternoon, the PGIMER email open on her screen, and made a decision. She pulled out her phone and called Dr. Rajesh Gupta, a general physician two floors below, twelve years in Chandigarh. "Rajesh," she said, "I need to talk through a case. PGIMER is asking if I want to do an echo on a patient with resolved musculoskeletal chest pain, normal ECG, normal troponin, and no cardiac findings. What would you do?"

Rajesh was quiet. Then: "If you do the echo and it is normal, you have reassured the patient and generated a report saying 'no evidence of structural disease.' If you do not do the echo and the patient is fine in two years, you have avoided an unnecessary investigation. But if you do not do the echo and the patient has something in two years, the chart will show 'chest pain evaluation, no imaging' and someone will ask why."

"So you would do it."

"I would do it. Not because the patient needs it clinically. Because the liability and the institutional pressure make it defensible to do it."

"That," Priya said, "is exactly the problem."

She installed the agent on her clinic tablet that evening. Set it to Hindi and Punjabi. The next morning, before her 10 AM consultations, she used it to structure her thinking about Vikram's case and the PGIMER email.

"કાર્ડિયાક ગાઈડલાઈન્સ કયી કહે છે musculoskeletal chest pain માટે જ્યારે ટ્રોપોનિન normal હોય? ACC કે ESC?"

(What do the cardiac guidelines say about echocardiography for musculoskeletal chest pain when troponin is normal? ACC or ESC?)

The agent pulled the relevant sections: American College of Cardiology 2021 guidelines recommended echocardiography for patients over 55 with risk factors and ongoing chest discomfort. Choosing Wisely, the collaboration between specialty societies and the American Board of Internal Medicine, specifically recommended against imaging in patients with resolved symptoms and normal baseline testing.

"તો બન્ને true છે? બોટ expert સોર્સ, પણ અલગ આંસર?"

(So both are true? Both expert sources, but different answers?)

The agent laid it out plainly:

"હા. ACC ગાઈડલાઈન્સ કહે છે: 52-year-old, sedentary, untreated cholesterol = do imaging. Choosing Wisely કહે છે: resolved symptoms + normal baseline = skip imaging. બંને clinically reasonable. તમારી clinic બાકી બીજા 47 કેસ માટે — જેમાં symptoms resolved છે, troponin normal છે, અને patient reassured છે — તમે કયો path લો છો?"

(Yes. ACC guidelines say: 52-year-old, sedentary, untreated cholesterol equals do imaging. Choosing Wisely says: resolved symptoms plus normal baseline equals skip imaging. Both clinically reasonable. For your clinic's other 47 cases where symptoms resolved, troponin normal, patient reassured — which path do you take?)

Priya read that three times. The agent was not telling her what to do. It was showing her the gap: that her decision in Vikram's case pointed to a systemic choice about how she practices.

"જો હું ૪૭ કેસમાં echo કરું, તો PGIMER happy છે, liability covered છે, CGHS reimbursement ₹70,500 છે. જો હું ૪૭ કેસમાં skip કરું, તો તમે કહો કે તે clinically defensible છે?"

(If I do echo on 47 cases, PGIMER is happy, liability covered, CGHS reimbursement is ₹70,500. If I skip on 47 cases, you're telling me that is clinically defensible?)

The agent replied:

"હા. Choosing Wisely, આ exact scenario માટે, એક study 2023 માં બતાવ્યું : જ્યારે symptoms resolved હોય અને troponin normal હોય, baseline echo કરવો vs. skip કરવો — બંને outcomes same છે 2-year follow-up માં. બીજો તરફ, unnecessary imaging ₹70,500 ખર્ચ કરે છે, અને false positives generate કરે છે જે future anxiety પ્રમાણે unnecessary follow-ups ચલાવે છે. તમે જ decision take કરો પણ ટેટ્રેજી clear છે: ₹70,500 વર્સ્ટ rational practice vs. liability protection."

(Yes. Choosing Wisely, for this exact scenario, one 2023 study showed: when symptoms resolved and troponin normal, doing baseline echo versus skipping — both had same outcomes at 2-year follow-up. On the other hand, unnecessary imaging costs ₹70,500 and generates false positives that drive future anxiety and unnecessary follow-ups. You make the decision, but the tradeoff is clear: ₹70,500 revenue versus rational practice versus liability protection.)

That afternoon, Priya composed a careful email to Dr. Verma at PGIMER. She wrote: "Thank you for your inquiry regarding Mr. Vikram Singh. I have reviewed the case and the clinical presentation carefully. His pain presentation is pleuritic, his ECG is normal, and his high-sensitivity troponin is normal. His symptoms have completely resolved. In accordance with Choosing Wisely guidelines, I am recommending against baseline echocardiography at this time, with clinical follow-up in three months. If his symptoms recur or his risk factors are not addressed (cholesterol management, exercise), we will revisit imaging. I will share these recommendations with the patient in writing."

The email was a risk. It named a guideline that contradicted PGIMER's question. It put on the record that she had chosen restraint over investigation. It made her reasoning visible.

Dr. Verma replied within hours: "Thank you for the detailed response. Your clinical reasoning is sound. We will await Vikram's follow-up. If anything changes, please refer."

What happened next was not a rescue. It was Priya noticing, a month later, that she had ordered six echos across her remaining caseload that month instead of the usual thirteen. Six was still driven partly by economics — she needed the CGHS reimbursement. But six was also a choice. The agent had made visible what the choice was.

What it does

• 🔍Surfaces conflicting guidelines — shows that imaging is sometimes defensible, sometimes not, and which guideline source argues which way.
• 🗂️Calculates the financial impact of a clinical choice — if Priya skips imaging on resolved-symptom cases, what is the revenue loss versus the diagnostic accuracy gain.
• 📊Tracks practice patterns — across a rolling three-month window, what fraction of Priya's chest-pain cases are getting imaging, how does it compare to Choosing Wisely benchmarks?

What it does not do

• 🔒Never tells a doctor to order or skip a test. Never enters patient records or PHI. Never submits referrals without explicit sign-off.
• 💳Never changes a billing code or submits a claim. The doctor retains all decisions around investigation and reimbursement.
• ✅Never decides for the clinic. It shows the tradeoff — economic, clinical, and liability — and lets Priya choose.

Vikram, six months later, remains off cardiac imaging. His cholesterol is being managed. His musculoskeletal pain never recurred. His chest remains benign. The case resolved exactly as clinical reasoning predicted. But what stayed with Priya was not the outcome. It was the knowledge that she had resisted a system designed to make the economically rational choice feel clinically necessary.

🧭 Why we built it

What Priya was experiencing was not unique to her practice. It was systemic to Chandigarh's medical ecosystem. The city had undergone explosive growth in diagnostic imaging over the past decade. Seventy-three registered ultrasound and imaging centers by 2025. One imaging center per 13,000 people — compared to the national average of one per 40,000. Oversupply had driven prices down. A two-dimensional echocardiogram, ₹3,000 five years ago, now cost ₹1,500 to ₹1,800.

The economics of these centers depended on volume. A center with one ultrasound machine needed approximately 40 to 50 echoes per day to break even. That required direct patient referrals and standing relationships with private clinics and hospitals. Priya's clinic had no in-house imaging. If she ordered an echo, she sent the patient to one of three imaging centers within walking distance of her practice, each with a standing referral relationship. She did not receive a direct commission, but the volume kept the referral relationship alive.

The financial incentive was toward investigation, not restraint. She did not get paid for saying "you do not need an echo." She did get paid — indirectly, through volume and reputation — for ordering the echo.

And then there was the CGHS constraint. CGHS covered government employees, retired military, and PSU workers — and Chandigarh had an unusually large CGHS population due to the high concentration of government offices and military personnel. CGHS reimbursement was fixed: ₹600 for a consultation, ₹1,500 for an echocardiogram, ₹800 for an angiogram. These rates had not changed since 2022.

🏥

Fixed clinic costs

₹110,000/month (rent + staff + utilities)

Baseline overhead requires 40-50 CGHS consultations monthly at ₹600 each. Additional investigations (₹1,500 per echo) are the only way to reach ₹80,000/month income target.

📊

CGHS reimbursement cap

Unchanged since 2022

No negotiation possible. Cannot offer discount for patient who wants consultation without investigation. Locked into rate. Margin pressure forces investigation.

🔍

Diagnostic center volume

40-50 echoes/day per center to break even

Imaging centers depend on referral relationships. Priya's patient volume sustains the referral pipeline. Ordering investigations keeps the network alive.

The frontier in Chandigarh's medical ecosystem is not a shortage of expertise. Hundreds of cardiologists exist there. It is not a lack of diagnostic tools. Imaging is abundant. The frontier is the gap between what medicine can do and what it should do, made wide by an economic system that compensates volume, not judgment. The best cardiologist in Chandigarh is, by current logic, the one who orders the most tests and maintains the strongest referral relationships. The cardiologist who practices restraint faces a narrowing margin and an invisible cost: the knowledge that she has chosen clinical integrity over financial sustainability.

That is what we built the agent for. Not to tell doctors what to do. Not to practice medicine without a license. But to make visible — in Hindi, in Punjabi, in the languages Chandigarh's doctors think in — what the choice actually is. Choosing Wisely versus ACC. Restraint versus defensibility. ₹70,500 of revenue versus two years of equivalent clinical outcomes.

Priya is still running her clinic Monday to Saturday. Her May revenue reached ₹78,000 — lower than baseline, but earned with fewer investigations per patient. She is thinking about a conversation with three cardiologists she trusts, all in Chandigarh, all in private practice. The question is not how to make individual doctors practice more restraint. It is how to build a system where restraint is rewarded and over-investigation is penalized. Until that system exists, the gap remains — wide, visible, and structurally costly.

🌱 What we hope happens

There is a particular moment in a cardiologist's practice when she stops asking "Is this test defensible?" and starts asking "Is this test necessary?" The two questions are not the same. Defensibility is about liability and institutional expectation. Necessity is about whether a patient's care improves. In Chandigarh's high-density specialist ecosystem, those two questions point in different directions. The system has made it safer to over-investigate than to restrain.

What we hope happens is that doctors like Priya — and there are more of them than the economics suggest — begin to notice the gap and ask the second question first. Not out of altruism. Out of the recognition that a system which compensates volume, not judgment, corrupts both the doctor and the patient. The patient gets unnecessary imaging. The doctor gets revenue, but loses the thing that made her become a cardiologist: the ability to see the patient clearly and to recommend only what the patient needs.

Chandigarh is the proving ground. If restraint can become defensible — if guidelines can be cited, if outcomes can be tracked, if the financial pressure can be acknowledged rather than hidden — then the frontier between what we can do and what we should do becomes navigable. Not resolved. But visible. And visibility is where change begins.

For private practitioners who want to practice with clarity instead of pressure, the agent is free at gabforge.in. We have the guidelines — Choosing Wisely, ACC, ESC, and the local Medical Council of Chandigarh regulations. We have the financial calculators. We have the practice-pattern trackers. And we will keep it free for the ones who choose to notice the gap.